AZN vs FIVE · P/E 28, $288.38B cap vs P/E 28, rev $1.39B
AstraZeneca PLC (AZN) versus Five Below Inc (FIVE) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Five Below Inc (FIVE) is a specialty retail company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Not investment advice. Open the AZN and FIVE stock pages for the full models.
Not investment advice.